NASDAQ:GRCL

Gracell Biotechnologies Earnings Date, Estimates & History

$12.90
-0.89 (-6.45 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$12.90
Now: $12.90▼
$13.63
50-Day Range
$12.94
MA: $19.18▼
$24.97
52-Week Range
$12.30
Now: $12.90▼
$33.70
Volume51,366 shs
Average Volume149,136 shs
Market Capitalization$845.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Earnings

Gracell Biotechnologies (NASDAQ:GRCL) Earnings Information

Gracell Biotechnologies last released its earnings results on March 8th, 2021. The reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.11. Gracell Biotechnologies has generated $0.00 earnings per share over the last year.

Gracell Biotechnologies Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Gracell Biotechnologies (NASDAQ:GRCL) Earnings Estimates

2021 EPS Consensus Estimate: ($1.21)
2022 EPS Consensus Estimate: ($1.85)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.27)($0.20)($0.24)
Q2 20212($0.30)($0.28)($0.29)
Q3 20212($0.35)($0.29)($0.32)
Q4 20212($0.45)($0.28)($0.37)
Q1 20221($0.35)($0.35)($0.35)
Q2 20221($0.40)($0.40)($0.40)
Q3 20221($0.50)($0.50)($0.50)
Q4 20221($0.60)($0.60)($0.60)

Gracell Biotechnologies (NASDAQ GRCL) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/8/2021Q4($0.27)($0.16)Transcript
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/17/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.